BioNTech Vs. Moderna: Navigating The mRNA Landscape
Moderna and BioNTech are pioneering companies in mRNA technology, known for their fast development of highly effective COVID-19 vaccines. Both companies have the potential to transform the treatmen...
BioNTech says European Patent Office has declared Moderna patent invalid
COVID-19 vaccine maker BioNTech said on Tuesday the European Patent Office has declared as invalid an mRNA patent that has been invoked by Moderna in litigation about alleged an patent violation by...
3 Biotech Stocks You'll Regret Not Buying Soon: November 2023
Biotechnology is a booming industry recently focused on synthetic biology, biomanufacturing and gene editing. Biotech is seen as the key to the future, as it has the potential to cure diseases and ...
7 Underappreciated Biotech Stocks to Pick Up on the Cheap
Amid some rising questions for the economy, value-seeking investors may want to consider underappreciated biotech stocks. As a sector that, while not immune to broader pressures, generally manages ...
BioNTech SE (BNTX) Q3 2023 Earnings Call Transcript
BioNTech SE (NASDAQ:BNTX ) Q3 2023 Earnings Call Transcript November 8, 2023 8:00 AM ET Company Participants Victoria Meissner - VP, Strategy & IR Ugur Sahin - Co-Founder & CFO Ozlem Tureci - Chief...
BioNTech Posts a Profit, While Cutting Its Full-Year COVID Vaccine Sales Outlook
BioNTech (BNTX) slashed its outlook for sales of its COVID-19 vaccine, but its American depositary receipts (ADRs) jumped over 4% in early trading Monday after the biotech firm posted a surprise pr...
BioNTech slashes revenue outlook amid lower Covid vaccine sales
BioNTech SE has lowered its forecast for this year's Covid-19 vaccine sales by 20%, becoming the latest drugmaker to adjust its expectations in the post-pandemic era. The German company said it now...
Pfizer, BioNtech say flu-COVID shot generates immune response
Pfizer and German partner BioNTech said on Thursday that their vaccine to prevent flu and COVID-19 generated a strong immune response against the virus strains in early- to mid-stage trials.
Paxlovid contract renegotiation pushed Covid business over the edge, says BMO's Evan Seigerman
Evan Seigerman, BMO Capital Markets analyst, joins 'Closing Bell: Overtime' to discuss Pfizer and BioNTech cutting guidance amid Covid sales falling, the weight loss boom, and more.
Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting Demand
Pfizer slashed its revenue forecasts on Friday amid falling demand for its Covid vaccine and antiviral drug Paxlovid.
Pfizer and BioNtech take big write-downs on Covid jab stocks
Covid vaccine developer BioNTech is to take a write-down of up to €900 million on its stocks of jabs following a similar provision by partner Pfizer last week. Pfizer had said that the write-offs r...
Pfizer shares fall on guidance cut, weighing on BioNTech and Moderna stocks, and other shares on the move
Shares of Lululemon Athletica Inc. LULU, +1.00% rallied more than 5% after index provider S&P Dow Jones Indices said the stock will join the S&P 500 index SPX on Wednesday.
BioNTech will likely take 900 mln eur write-off on Pfizer-partnered vaccines
Germany's BioNTech on Monday said it would likely take write-downs of up to 900 million euros ($947 million) in the third quarter after its partner Pfizer reported similar charges on their COVID-19...
BioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress 2023
MAINZ, Germany, October 16, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present data across its oncology pipeline, covering multiple solid tumor types and novel mechanisms o...
Why Pfizer and BioNTech Stocks Zoomed Higher Today
While people in this country aren't rushing in masses to get updated COVID booster vaccines, take-up has been encouraging. Many are worried about an apparent resurgence in the affliction.
Related Companies